Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34607 | 0.97 | ALDH1A1 (0.32) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL584440 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Water SCHEMBL28212473 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Water SCHEMBL29258026 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Iodide SCHEMBL5143897 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL25396186 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Bromide SCHEMBL584276 | 0.94 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL4228173 | 0.94 | — | — | |
| Bromide SCHEMBL6882180 | 0.92 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 | |
| Silver SCHEMBL28022140 | 0.92 | ALDH1A1 (0.30) | ALDH1A1SMN1; SMN2CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | JIANGSU CELLURANICS NEW MATERIAL TECHNOLOGY CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| CN-115746037-B | Synthesis method of alpha-halogenated borate compound and product thereof | 同济大学 | 2025-03-14 | — | — | CN | claimed |
| EP-4477651-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | Jiangsu Celluranics New Material Technology Co., Ltd. (CN) | 2024-12-18 | — | — | EP | claimed |
| CN-117843428-A | endo/exo 3, 4-disubstituted tricyclo [4.2.1.0 2,5 ]Process for preparing non-3, 7-diene compound | 湖南师范大学 | 2024-04-09 | — | — | CN | claimed |
| CN-113735888-B | Synthetic method of isopropenylboronic acid pinacol ester | 大连双硼医药化工有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116903434-A | Copper-catalyzed method for preparing difluoromethyl olefin by hydrodefluorination of trifluoromethyl olefin | 凯美克(上海)医药科技有限公司 | 2023-10-20 | — | — | CN | claimed |
| WO-2023169517-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | 江苏赛瑞克新材料科技有限公司 | 2023-09-14 | — | — | WO | claimed |
| CN-116726864-A | Synthesis process of raw material for treating multiple myeloma proteasome inhibitor | 浙江美华鼎昌医药科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116712399-A | Preparation process of capsule for treating multiple myeloma proteasome inhibitor | 浙江美华鼎昌医药科技有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-115746037-A | Synthetic method of alpha-halogenated borate compound and product thereof | 同济大学 | 2023-03-07 | — | — | CN | claimed |
| CN-115613087-A | High-hardness nano Ni-Co-B alloy chromium-substituting electroplating solution and application thereof | 哈尔滨工业大学 | 2023-01-17 | — | — | CN | claimed |
| CN-113735888-A | Synthetic method of isopropenyl pinacol borate | 大连双硼医药化工有限公司 | 2021-12-03 | — | — | CN | claimed |
| CN-214334329-U | 1, 3-dicyclohexyl imidazole chloride's processing sampling device | 安庆睿升医药科技有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-113185736-A | Polyelectrolyte material for new energy automobile fuel cell and preparation method thereof | 邓文辉 | 2021-07-30 | — | — | CN | claimed |
| CN-110790649-A | Method for synthesizing polysubstituted α unsaturated ketone | 西北大学 | 2020-02-14 | — | — | CN | claimed |
| CN-102659919-A | Synthetic method of bortezomib | UNIV HEFEI TECHNOLOGY | 2012-09-12 | — | — | CN | claimed |
| US-12576365-B2 | Spiral membrane element and membrane separation system | NITTO DENKO CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| EP-4681801-A1 | GAS SEPARATION SYSTEM, AND MIXED GAS SEPARATION METHOD | Nitto Denko Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20100160683-A1 | Process for Production of 2-(Substituted Phenyl)-3,3,3-Trifluoropropene Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-24 | — | — | US | disclosed |
| US-6025496-A | Process for preparing heterocyclic carbenes | CELANESE GMBH (DE) | 2000-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160683-A1 | Process for Production of 2-(Substituted Phenyl)-3,3,3-Trifluoropropene Compound | PEX3, SCO2, LPO | ALDH1A1 3618/4885SMN1; SMN2 2168/4885CYP3A4 1605/4885 |
| US-20250188048-A1 | METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID COMPOUND | HPD, DPYD, PGD | ALDH1A1 624/4885SMN1; SMN2 4474/4885CYP3A4 432/4885 |
| US-12576365-B2 | Spiral membrane element and membrane separation system | PCTP, TIMM9, AQP1 | ALDH1A1 4873/4885SMN1; SMN2 2801/4885CYP3A4 4075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.